Scientists uncover new gut microbes in Africa and say their findings could help make medicines more effective.

HIV infections are lifelong and can weaken the immune system, causing a patient to be more susceptible to infection and ...

A preliminary study has found that efavirenz — a non-nucleoside inhibitor of HIV virus that is used for treating HIV/AIDS — can be repurposed for the treatment of chikungunya. Currently ...

Researchers have discovered that Daphne pseudomezereum (commonly known as Onishibari) contains a substance inhibiting ...

Researchers evaluated the potential clinical impact and cost-effectiveness of administering long-acting, injectable ...

Survey data suggests that over a third of organizations that relied on US funding for HIV services had already closed by ...

March 17 (Reuters) - The Trump administration's decision to pause U.S. foreign aid has "substantially disrupted" supply of HIV treatments in eight countries, which could soon run out of these life ...

Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against mpox with 84% ...

GENEVA – The Trump administration’s decision to pause US foreign aid has “substantially disrupted” the supply of human immunodeficiency virus (HIV) treatments in eight countries ...

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

(1 Trusted Source HIV weakens the immune system by attacking infection-fighting cells. While antiretroviral therapy controls the virus, it doesn’t cure it. Mount Sinai researchers ...